Skip to main content

Swift COronavirus therapeutics REsponse

Project description

A drug discovery programme against COVID-19

The COVID-19 pandemic has highlighted the lack of vaccines and drugs to tackle this health emergency. Scientists of the EU-funded SCORE project have previously worked to understand and inhibit coronavirus replication, unveiling key viral functions and developing appropriate tools for screening and identifying drug candidates. The project will build on this expertise to establish a state-of-the-art drug discovery approach for inhibitors active against evolving 2019-nCoV strains. Researchers will test already approved antivirals and design new ones that target virus entry into the cell, RNA replication and protein function. Preliminary results are expected within six to nine months, and selected compounds will be forwarded for development.

Call for proposal

H2020-SC1-PHE-CORONAVIRUS-2020
See other projects for this call

Coordinator

ACADEMISCH ZIEKENHUIS LEIDEN
Address
Albinusdreef 2
2333 ZA Leiden
Netherlands
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 449 375

Participants (7)

UNIVERSITE D'AIX MARSEILLE
France
EU contribution
€ 425 125
Address
Boulevard Charles Livon 58
13284 Marseille
Activity type
Higher or Secondary Education Establishments
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium
EU contribution
€ 681 562,50
Address
Oude Markt 13
3000 Leuven
Activity type
Higher or Secondary Education Establishments
UNIVERSITEIT UTRECHT
Netherlands
EU contribution
€ 325 000
Address
Heidelberglaan 8
3584 CS Utrecht
Activity type
Higher or Secondary Education Establishments
EIDGENOESSISCHES DEPARTEMENT DES INNERN
Switzerland
EU contribution
€ 250 000
Address
Inselgasse 1
3003 Bern
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
UNIVERSITAET zu LUEBECK
Germany
EU contribution
€ 325 000
Address
Ratzeburger Allee 160
23562 Lubeck
Activity type
Higher or Secondary Education Establishments
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Germany
EU contribution
€ 120 000
Address
Inhoffenstrasse 7
38124 Braunschweig
Activity type
Research Organisations
JANSSEN PHARMACEUTICA NV
Belgium
EU contribution
€ 0
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)